Liposomal Bupivacaine for Pain Control Following Anterior Cruciate Ligament Reconstruction
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
This study will consist of 80 patients ages 18 to 50 at the Emory Orthopaedic and Spine
Center who are undergoing Anterior Cruciate Ligament (ACL) reconstruction with a quadriceps
tendon autograft or bone patellar tendon bone autograft by Dr. Karas or Dr. Xerogeanes.
Patients will be randomized into treatment and control arms. The treatment arm will include
40 patients receiving liposomal bupivacaine intra-operatively in addition to the current
standard pain control regimen. The control group will include 40 patients receiving the
standard post-operative pain control regimen. Patients will be assessed to identify
differences in post-operative pain, satisfaction, as well as concomitant pain medication use.
Post-operative range of motion will also be assessed.